Lamivudine vs no intervention
Serious adverse events (6 to 12 months) · people with acute HBV infection
1 finding from 1 review
- Pharmacological interventions for acute hepatitis B infection 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 250 participantsVery low